Antibacterial properties of Acinetobacter baumanniiphage Abp1 endolysin (PlyAB1)

[1]  D. Paterson,et al.  Prevalence of multidrug-resistant organisms and risk factors for carriage in long-term care facilities: a nested case-control study. , 2014, The Journal of antimicrobial chemotherapy.

[2]  G. Volckaert,et al.  Engineered Endolysin-Based “Artilysins” To Combat Multidrug-Resistant Gram-Negative Pathogens , 2014, mBio.

[3]  M. Menéndez,et al.  Improving the Lethal Effect of Cpl-7, a Pneumococcal Phage Lysozyme with Broad Bactericidal Activity, by Inverting the Net Charge of Its Cell Wall-Binding Module , 2014, Antimicrobial Agents and Chemotherapy.

[4]  Yun-Jaie Choi,et al.  Preclinical Safety Evaluation of Intravenously Administered SAL200 Containing the Recombinant Phage Endolysin SAL-1 as a Pharmaceutical Ingredient , 2014, Antimicrobial Agents and Chemotherapy.

[5]  Yunsong Yu,et al.  Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. , 2013, International journal of antimicrobial agents.

[6]  N. Suttorp,et al.  Delivery of the endolysin Cpl-1 by inhalation rescues mice with fatal pneumococcal pneumonia. , 2013, The Journal of antimicrobial chemotherapy.

[7]  M. Menéndez,et al.  Improving the Lethal Effect of Cpl-7, a Pneumococcal Phage Lysozyme with Broad Bactericidal Activity, by Inverting the Net Charge of Its Cell Wall-Binding Module , 2013, Antimicrobial Agents and Chemotherapy.

[8]  Anren Hu,et al.  Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978. , 2013, International journal of antimicrobial agents.

[9]  R. Liddington,et al.  The secondary cell wall polysaccharide of Bacillus anthracis provides the specific binding ligand for the C-terminal cell wall-binding domain of two phage endolysins, PlyL and PlyG. , 2013, Glycobiology.

[10]  S. Kulakauskas,et al.  A Novel Type of Peptidoglycan-binding Domain Highly Specific for Amidated d-Asp Cross-bridge, Identified in Lactobacillus casei Bacteriophage Endolysins* , 2013, The Journal of Biological Chemistry.

[11]  P. Su,et al.  Identification of a Novel Antimicrobial Peptide from Human Hepatitis B Virus Core Protein Arginine-Rich Domain (ARD) , 2013, PLoS pathogens.

[12]  Shuai Le,et al.  Characterization and Genome Sequencing of Phage Abp1, a New phiKMV-Like Virus Infecting Multidrug-Resistant Acinetobacter baumannii , 2013, Current Microbiology.

[13]  F. Wen,et al.  Isolation and Characterization of φkm18p, a Novel Lytic Phage with Therapeutic Potential against Extensively Drug Resistant Acinetobacter baumannii , 2012, PloS one.

[14]  M. Loessner,et al.  Bacteriophage endolysins as novel antimicrobials. , 2012, Future microbiology.

[15]  F. Wen,et al.  Isolation and Characterization of phikm18p, a Novel Lytic Phage with Therapeutic Potential against Extensively Drug Resistant Acinetobacter baumannii , 2012 .

[16]  F. García-Godoy,et al.  Analysis by confocal laser scanning microscopy of the MDPB bactericidal effect on S. mutans biofilm CLSM analysis of MDPB bactericidal effect on biofilm , 2012, Journal of applied oral science : revista FOB.

[17]  Anren Hu,et al.  Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both Gram-positive and Gram-negative bacteria , 2011, Applied Microbiology and Biotechnology.

[18]  T. Tan,et al.  In Vitro Antibiotic Synergy in Extensively Drug-Resistant Acinetobacter baumannii: the Effect of Testing by Time-Kill, Checkerboard, and Etest Methods , 2010, Antimicrobial Agents and Chemotherapy.

[19]  S. Amyes,et al.  Characterization of Epidemiologically Unrelated Acinetobacter baumannii Isolates from Four Continents by Use of Multilocus Sequence Typing, Pulsed-Field Gel Electrophoresis, and Sequence-Based Typing of blaOXA-51-like Genes , 2010, Journal of Clinical Microbiology.

[20]  S. Jia,et al.  Isolation and Characterization of a Virulent Bacteriophage AB1 of Acinetobacter baumannii , 2010, BMC Microbiology.

[21]  M. Adams,et al.  Comparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii , 2008, Journal of bacteriology.

[22]  Harald Seifert,et al.  Acinetobacter baumannii: Emergence of a Successful Pathogen , 2008, Clinical Microbiology Reviews.

[23]  L. Dijkshoorn,et al.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii , 2007, Nature Reviews Microbiology.

[24]  J. Weissenbach,et al.  Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii , 2006, PLoS genetics.

[25]  F. Rodríguez-Valera,et al.  Development of a Multilocus Sequence Typing Scheme for Characterization of Clinical Isolates of Acinetobacter baumannii , 2005, Journal of Clinical Microbiology.

[26]  M. Loessner,et al.  Bacteriophage endolysins--current state of research and applications. , 2005, Current opinion in microbiology.

[27]  P. Jollès,et al.  What's new in chitinase research? , 1992, Experientia.

[28]  P. von Dippe,et al.  Characterization of the bile acid transport system in normal and transformed hepatocytes. Photoaffinity labeling of the taurocholate carrier protein. , 1983, The Journal of biological chemistry.